Document Detail

Cushing's syndrome during pregnancy secondary to adrenal adenoma: metyrapone treatment and laparoscopic adrenalectomy.
MedLine Citation:
PMID:  16610244     Owner:  NLM     Status:  MEDLINE    
Cushing's syndrome during pregnancy is a rare and difficult to diagnose disorder. We describe the case of a 30-yr-old woman presenting with symptoms and signs of mild hypercortisolism, in which ACTH-independent Cushing's syndrome was diagnosed. Urinary cortisol excretion was elevated and circadian rhythm of cortisol was absent. ACTH levels were low. In addition, plasma cortisol failed to suppress after a high dexamethasone dose. An abdominal computed tomography scan confirmed a left adrenal mass. While diagnosis work-up was still in progress, the patient became pregnant and wanted to carry her pregnancy to full-term. Hypercortisolism was successfully controlled with metyrapone, which was started at 8 weeks of gestation. At 16 weeks of gestation, a laparoscopic left adrenalectomy was performed. Pathologic examination of the gland showed a benign adrenocortical adenoma. The patient developed secondary adrenal insufficiency and was discharged on 20 mg hydrocortisone daily dose. At 30 weeks of gestation, the patient had a pre-term rupture of membranes and underwent spontaneous vaginal delivery. The newborn was a normal virilized male who weighed 1280 g. No apparent metyrapone-induced teratogenic effects were observed and there was no clinical or biochemical suppression of adrenocortical function. In conclusion, in adrenal Cushing's syndrome during pregnancy, medical treatment with metyrapone as soon as the diagnosis is made, in combination with laparoscopic surgery during the second trimester, are useful in preventing complications secondary to hypercortisolism and safe both for the mother and infant.
C Blanco; E Maqueda; J A Rubio; A Rodriguez
Related Documents :
4040814 - Stereological analysis of daily variation in the ultrastructure of the pars intermedia ...
25098024 - The third stage of labor: a study of outcomes in the second trimester of pregnancy.
7240674 - Partial remission of hyperprolactinemic amenorrhea after bromocriptine-induced pregnancy.
12114694 - Vascularity in nontumorous human pituitaries and incidental microadenomas: a morphometr...
24468574 - Maternal exposure to bisphenol a may increase the risks of parkinson's disease through ...
10721924 - Anemia, iron and pregnancy outcome.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Journal of endocrinological investigation     Volume:  29     ISSN:  0391-4097     ISO Abbreviation:  J. Endocrinol. Invest.     Publication Date:  2006 Feb 
Date Detail:
Created Date:  2006-04-13     Completed Date:  2006-06-05     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7806594     Medline TA:  J Endocrinol Invest     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  164-7     Citation Subset:  IM    
Department of Endocrinology, Hospital Principe de Asturias, University of Alcalá, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adenoma / complications*
Adrenal Gland Neoplasms / complications*
Cushing Syndrome / therapy*
Enzyme Inhibitors / therapeutic use
Metyrapone / therapeutic use*
Pregnancy Complications / therapy*
Reg. No./Substance:
0/Enzyme Inhibitors; 54-36-4/Metyrapone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The potential role of increased adrenal volume in the pathophysiology of obesity-related type 2 diab...
Next Document:  Spindle cell metaplasia arising in thyroid adenoma: characterization of its pathology and differenti...